The grant, which would have benefitted the Birmingham Biotechnology Hub, led by Southern Research, has been cancelled. The ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Biotechnology company Regeneron Pharmaceuticals ... notably spanning from a 2023 data breach - along with questions around what new ownership could mean for users' data. RELATED: 23andMe ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...

Following a regulatory setback last year, Satsuma Pharmaceuticals Inc. has won approval for its nasal powder migraine ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Alicia Alford, a recent graduate of the BULLS Life Sciences Academy and Durham Technical Community College, said Accelerate NC had helped her get her new “big girl job” as a Manufacturing Associate I ...

Old royalty assumptions Several simple ... consider your profitability as a measure of success. New royalty approaches Pharmaceutical and biotechnology companies today use varying techniques ...

Biotechnology company Regeneron Pharmaceuticals ... notably spanning from a 2023 data breach — along with questions around what new ownership could mean for users’ data. US spring homebuying ...